Učitavanje...
The role of Asprosin in patients with dilated cardiomyopathy
BACKGROUND: Asprosin is a novel fasting glucogenic adipokine discovered in 2016. Asprosin induces rapid glucose releases from the liver. However, its molecular mechanisms and function are still unclear. Adaptation of energy substrates from fatty acid to glucose is recently considered a novel therape...
Spremljeno u:
| Izdano u: | BMC Cardiovasc Disord |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7487662/ https://ncbi.nlm.nih.gov/pubmed/32894050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-020-01680-1 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|